One of the most promising fluid biomarkers is glial fibrillary acidic protein (GFAP), which reflects astrocytic reactivity and is significantly elevated in the cerebrospinal fluid (CSF) and serum of patients with secondary and primary progressive MS [67,68]. Here, GFAP is linked to primary progressive multiple sclerosis.